Adjuvant post-operative therapy

Bailliere's Clinical Gastroenterology

Volumn 12, Issue 1, 1998, Pages 179-199

  Leiper, Keith ^a,c   London, Ian ^a,c   Rhodes, Jonathan M ^b,c  

^a Medicine (Gastroenterology)

^b Department of Medicine ^*

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Crohn's disease; Mesalazine; Metronidazole; Post operative maintenance

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CORTICOSTEROID; FISH OIL; MESALAZINE; METRONIDAZOLE;

ADJUVANT THERAPY; ARTICLE; CROHN DISEASE; DIET; ENDOSCOPY; FAT INTAKE; HUMAN; MAINTENANCE THERAPY; ORAL DRUG ADMINISTRATION; PERIPHERAL NEUROPATHY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RELAPSE; SMOKING;

EID: 0031818784     PISSN: 09503528     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3528(98)90092-6     Document Type: Article

References (81)

1. Alun Jones V, Workman E, Freeman AH et al (1985) Crohn's disease: maintenance of remission by diet. Lancet i: 177-180.
2. Arber N, Odes HS Fireman Z et al (1995) A controlled double blind multicentre study of the effectiveness of 5-aminosalicyclic acid in patients with Crohn's disease in remission. Journal of Clinical Gastroenterology 20: 203-206.
3. Archambault A, Feagan B, Fedorak R et al (1992) The Canadian Crohn's Relapse Prevention Trial (CCRPT). Gastroenterology 102: A591. (Abstract).
4. Baron JH, Bennett PN, Lennard Jones J et al (1977) Sulphasalazine in asymptomatic Crohn's disease. Gut 18: 69-72.
5. *Belluzzi A, Brignola C, Campieri M et al (1996) Effect of an enteric coated fish oil preparation on relapses in Crohn's disease. New England Journal of Medicine 334: 1557-1560.
6. Bergman L & Krause U (1976) Postoperative treatment with corticosteroids and salazosulphapyridine (Salazopyrin). Scandinavian Journal of Gastroenterology 11: 651-656.
7. Bondesen S & The Danish 5-ASA Group (1991) Mesalazine (Pentasa) as prophylaxis in Crohn's disease. A multicenter, controlled trial. Scandinavian Journal of Gastroenterology 26: F44. (Abstract).
8. Boughnik Y, Lemann M, Mary JY et al (1996) Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet 347: 215-219.
9. Bowling TE (1995) Nutrition for gastroenterologists: inflammatory bowel disease. European Journal of Gastroenterology and Hepatology 7: 521-527.
10. Breuer-Katschinski BD, Hollander N & Goebell H (1996) Effect of cigarette smoking on the course of Crohn's disease. European Journal of Gastroenterology and Hepatology 8: 225-228.
11. O'Brien J, Eilering D & Dalavais J (1997) Evening primrose oil in the treatment of Crohn's disease. Gastroenterology 112: A1052. (Abstract).
12. Brignola C, Iannone P, Pasquali S et al (1992) Placebo controlled trail of oral 5-ASA in relapse prevention of Crohn's disease. Digestive Diseases and Sciences 37: 29-32.
13. Brignola C, Cottone M, Pera A et al (1995) Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Gastroenterology 108: 345-349.
14. Brzezinski A & Lashner BA (1997) Natural history of Crohn's disease. In Allan RN, Rhodes JM, Hanauer SB, Keighley MRB, Alexander-Williams J, Fazio VW (eds) Inflammatory Bowel Diseases, pp 475-486. New York: Churchill Livingstone.
15. Caprilli R, Andreoli A, Capurso L et al (1994) Oral mesalazine (5-aminosalicylic acid: Asacol) for the prevention of post operative recurrence of Crohn's disease. Alimentary Pharmacology and Therapeutics 8: 35-43.
16. Connell WR, Kamm MA, Dickson M et al (1994) Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 343: 1249-1252.
17. *De Dombal FT, Burton I & Goligher JC (1971) Recurrence of Crohn's disease after primary excisional surgery. Gut 12: 519-527.
18. *O'Donoghue DP, Dawson AM, Powel-Tuck K & Brown RL (1978) Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease. Lancet ii: 944-946.
19. van Dulleman HM, van Deventer SJH, Homes DW et al (1995). Treatment of Crohn's disease with anti-tumour necrosis factor monoclonal antibody (cA2). Gastroenterology 109: 129-135.
20. Egan LJ & Sandborn WJ (1996) Methotrexate for inflammatory bowel disease: pharmacology and preliminary results. Mayo Clinical Proceedings 71: 69-80.
21. Endres S, Ghorbani R, Kelly VE et al (1989) The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1β and tumour necrosis factor by mononuclear cells. New England Journal of Medicine 320: 265-271.
22. Evans RC & Rhodes JM (1996) Understanding the mechanism of dietary therapy in Crohn's disease - meta-analysis of polymeric enterai feeding studies and pilot study of maintenance with low fibre/low fat diet. Gut 38: A637. (Abstract).
23. Ewe K, Herfarth HC, Malcho WH & Jesdinsky HJ (1989) Post operative recurrence of Crohn's disease in relation to radicality of operation and sulphasalazine prophylaxis. Digestion 42: 224-232.
24. Ewe K, Press AG, Singe C et al (1993) Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease Gastroenterology 105: 367-372.
25. Feagan BG, Rochon J, Fedorak RN et al (1995) Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators. New England Journal of Medicine 332(5): 292-297.
26. Fernandez-Banares F, Cabre E, Gonzalez-Huiz F & Gassull MA (1994) Enteral nutrition as primary therapy in Crohn's disease. Gut 35 (supplement 1): S55-59.
27. Fiasse R, Fontaine F & Vanheuverzwyn R (1991) Prevention of Crohn's disease recurrences after intestinal resection with Eudragit-L coated 5-aminosalicylic acid: preliminary results of a one year double-blind placebo controlled study. Gastroenterology 100: A208. (Abstract).
28. *Florent C, Cortot A, Quandale P et al (1996) Placebo controlled trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. European Journal of Gastroenterology and Hepatology 8: 229-233.
29. De Franchis R, Brignola C, Del Piano M et al (1994) Oral 5-aminosalicylic acid in the prevention of early relapse of Crohn's disease, interim analysis of a multicenter double blind randomised placebo controlled trial. Gastroenterology 106: A670. (Abstract).
30. Gendre JP, Mary JV, Florent C et al (1993) Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo controlled study. Gastroenterology 104: 435-439.
31. Godet PG, May GR & Sutherland LR (1995) Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease. Gut 37: 668-673.
32. Greenberg GR, Feagan BG, Martin F et al (1996) Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group. Gastroenterology 110(1): 45-51.
33. *Greenstein AJ, Lachman P, Sachar DB et al (1988) Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut 29: 588-592.
34. Gross V, Andus T, Ecker KW et al (1995) Oral pH-modified release budesonide for maintenance of steroid induced remission in Crohn's disease. Gut 37 (supplement 2): 967. (Abstract).
35. D'Haens G, Geboes K, Ponette E et al (1997) Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease. Gastroenterology 112: 1475-1481.
36. Heaton KW, Thornton JR & Emmett PM (1979) Treatment of Crohn's disease with an unrefined-carbohydrate, fibre-rich diet. British Medical Journal 2: 764-766.
37. Hilsden RL & Sutherland LR (1996) Medical and nutritional therapy for Crohn's disease. Current Opinion in Gastroenterology 12: 356-362.
38. Lederman E, Neut C, Desreumaux P et al (1997) Bacterial overgrowth in the neoterminal ileum after ileocolonic resection for Crohn's disease. Gastroenterology 112: A1023. (Abstract).
39. Levenstein S, Prantera C, Luzi C & D'Ubaldi A (1985) Low residue or normal diet in Crohn's disease: a prospective controlled study in Italian patients. Gut 26: 989-993.
40. Lochs H, Mayer M, Fleig WE et al (1997) Prophylaxis of post operative relapse in Crohn's disease with mesalazine (Pentasa) in comparison with placebo. Gastroenterology 112: A1027. (Abstract).
41. Lofberg R, Rutgeerts P, Malchow H et al (1994) Budesonide CIR for maintenance of remission in ileocaecal Crohn's disease. A European multicentre placebo controlled trial for 12 months. Gastroenterology 106: A722. (Abstract).
42. Lorenz-Meyer H, Bauer P, Nicolay C et al (1996) Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. Scandinavian Journal of Gastroenterology 31: 778-785.
43. Lorenz R, Weber PC, Szimnau P et al (1989) Supplementation with n-3 fatty acids from fish oils in chronic inflammatory bowel disease - a randomised placebo-controlled, double-blind crossover trial. Journal of Internal Medicine 225 (supplement 731): 225-232.
44. *McLeod RS, Wolff BG, Steinhart AH et al (1995) Prophylactic mesalamine treatment decreases post operative recurrence of Crohn's disease. Gastroenterology 109: 404-413.
45. MacIntyre DE, Hoover RL, Smith M et al (1984) Inhibition of platelet function by cis unsaturated fatty acids. Blood 63: 848-857.
46. Malchow H, Ewe K, Brandes JW et al (1984) European Cooperative Crohn's Disease Study (ECCDS); results of drug treatment. Gastroenterology 86: 249-266.
47. Mate J, Castanos R, Garcia-Samaniego J & Pajares JM (1991) Does dietary fish oil maintain the remission of Crohn's disease (CD): a case control study. Gastroenterology 100: A228. (Abstract).
48. Mauvis F, Panis Y, Nemeth J et al (1996) Influence of azathioprine on postoperative recurrence after ileocaecal resection for Crohn's disease. Gut 39 (supplement 3): A249. (Abstract).
49. Messori A, Brignola C, Trallori G et al (1994). Effectiveness of 5-aminosalicylic acid for maintaining remission in patients with Crohn's disease: a metaanalysis, American Journal of Gastroenterology 89: 692-698.
50. Middleton SJ, Rucker JT, Kirby GA et al (1995) Long-chain triglycerides reduce the efficacy of enteral feeds in patients with active Crohn's disease. Clinical Nutrition 14: 229-236.
51. Modigliani R, Colombel JF, Dupas JL et al (1996) Mesalamine in Crohn's disease with steroid induced remission: effect on steroid withdrawal and remission maintenance. Gastroenterology 110: 688-693.
52. Murch SH & Walker-Smith JA (1994) Medical management of chronic inflammatory bowel disease. Baillière's Clinical Gastroenterology 8(1): 133-148.
53. Nagel E, Schattenfroh S, Buhner S et al (1993). Animal experiment studies of ultrastructural changes in the lamina propria of the ileum caused by dietary fats and comparison with cytopathology in Crohn's disease. Zeitschrift fur Gastroenterologie 31: 727-734.
54. Oliason G, Smedh K & Sjodahl R (1992) Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers proceeding symptoms. Gut 33: 331-335
55. Pimpo MT, Frierir G, Palumbo G et al (1997) Post operative recurrence of Crohn's disease and 5-ASA mucosal concentration. A GISC study. Gastroenterology 112: A1061. (Abstract).
56. Prantera C, Pallone F, Brunetti G et al (1992) Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease. Gastroenterology 103: 363-368.
57. Present DH (1995) The prevention of Crohn's disease after surgery: metronidazole is a small but continuous advancement. Gastroenterology 108: 1935-1938.
58. Present DH, Korelitz BI, Wisch N et al (1980) Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomised, double-blind study. New England Journal of Medicine 302: 981-987.
59. Rampton DS & Collins CE (1993) Thromboxanes in inflammatory bowel disease - pathogenic and therapeutic implications. Alimentary Pharmacology and Therapeutics 7: 357-367.
60. Raouf AH, Hildrey V, Daniel J et al (1991) Enteral feeding as sole therapy for Crohn's disease: a controlled trial of whole protein versus amino-acid based feed and a case study of dietary challenge. Gut 32: 702-707.
61. Rhodes JM, Cockel R, Allan RN et al (1983) Colonic Crohn's disease and the contraceptive pill. British Medical Journal 288: 595-596.
62. Ritchie J, Wadsworth J, Lennard Jones J & Rogers E (1985) Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. British Medical Journal 295: 517-520.
63. *Rutgeerts P, Heilr M & Geboes K (1995) Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 108: 1617-1621.
64. Rutgeerts P, Geboes K, Vantrappen G et al (1990) Predictability of the post operative course of Crohn's disease. Gastroenterology 99: 956-963.
65. Rutgeerts P, Lofberg R, Malchow H et al (1994) A comparison of budesonide with prednisolone for active Crohn's disease. New England Journal of Medicine 331: 842-845.
66. Seidman EG, Roy CC, Weber AM & Morin CL (1987) Nutritional therapy of Crohn's disease in childhood. Digestive Diseases and Sciences 32 (supplement 12): 825-885.
67. Smith RC, Rhodes J, Heatley RV et al (1978) Low dose steroids and clinical relapse in Crohn's disease: a controlled trial. Gut 19: 606-610.
68. Stack WA, Mann SD, Roy AJ et al (1997) A randomised controlled trial of CDP571 antibody to tumour necrosis factor -alpha in Crohn's disease. Lancet 349: 521-524.
69. Stange EF, Modigliani R, Pena AS et al (1995) European trial of cyclosporine in chronic active Crohn's disease: a 12-month study. Gastroenterology 109: 774-782.
70. Steinhart AH, Hemphill D & Greenberg GR (1994) Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis. American Journal of Gastroenterology 89: 2116-2124.
71. * Summers RW, Switz DM, Sessions JT et al (1979) National Cooperative Crohn's Disease Study : results of drug treatment. Gastroenterology 77: 847-869.
72. * Sutherland LR, Ramcharan S, Bryant H & Pick G (1990) Effects of cigarette smoking on the recurrence of Crohn's disease. Gastroenterology 98: 1123-1128.
73. Sutherland LR, Ramcharan S, Bryant H & Fick G (1992) Effect of oral contraceptive use on reoperation following surgery for Crohn's disease. Digestive Diseases and Sciences 37: 1377-1382.
74. Sutherland LR, Martin F, Bailey RJ et al (1995) 5-amino salicylic acid in the maintenance of remission of Crohn's disease. Gastroenterology 108: 924. (Abstract).
75. * Sutherland LR, Martin F, Bailey RJ et al (1997) A randomised, placebo controlled, double blind trial of mesalamine in the maintenance of remission in Crohn's disease. Gastroenterology 112: 1069-1077.
76. Thompson AB and the International Mesalazine Group (1990) Coated 5-aminosalicyclic acid (Asacol) in maintenance treatment of Crohn's disease. Alimentary Pharmacology and Therapeutics 4: 55-64.
77. Thompson AB, Wright JP, Vatn M et al (1995) Mesalazine (Mesasal/Claversal) 1.5 g bd vs placebo in the maintenance of remission of patients with Crohn's disease. Alimentary Pharmacology and Therapeutics 9: 673-683.
78. Tobin NV, Logan RFA, Langman MJS et al (1987) Cigarette smoking and inflammatory bowel disease. Gastroenterology 93: 316-321.
79. Wallace JL, Keenan CM & Finn NJ (1989) Antiinflammatory effects of a fish oil diet in a rat model of chronic colitis. Gastroenterology 96: A535. (Abstract).
80. Wenckert A, Kristensen M, Eklund AE et al (1978) The long term prophylactic effect of salazosulphapyridine (Salazopyrin) in primary resected patients with Crohn's disease. Scandinavian Journal of Gastroenterology 13: 161-167.
81. Whelan G, Farmer RG, Fazio VW & Goormastic M (1985) Recurrence after surgery in Crohn's disease. Gastroenterology 88: 1826-1833.